Search
Petmed Express Inc
PETSAdd to Watchlist
1.065USD
-0.145-11.98%
Close 11-11 16:00（ET）
23.09MMarket Cap
LossP/E TTM
Petmed Express Inc (PETS) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Petmed Express Inc in the past month.
Sell
0 Strong Buy
0 Buy
0 Hold
1 Sell
0 Strong Sell
Target Price
1.400USD+17.65%
PETS Analyst Recommendation Trends
In the current month, PETS has received 0 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. PETS average Analyst price target in the last month is 1.400.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
PETS Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Guardian Pharmacy Services Inc
GRDN
4
3
0
0
0
7
Glass House Brands Subordinate Voting Ord Shs Class A
GLAS
0
3
0
0
0
3
High Tide Inc
HITI
0
2
0
0
0
2
IM Cannabis Corp
IMCC
0
0
0
0
0
0
Financial Forecasting
Based on analysts' estimates, PETS EPS is projected to reach -0.110 in FY2027Q3, following reported EPS of -0.310 in FY2027Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
FY2027Q4
Forecast
-0.18
0.12
-0.06
-0.11
0.12
Actual
-0.19
-0.28
-0.31
--
--
Surprise
-7.28%
-336.18%
-416.67%
--
--
FAQs
What is Petmed Express Inc's price target?
Analysts forecast that Petmed Express Inc's price target is USD 1.40, with the highest forecast at USD 1.40 and the lowest forecast at USD 1.40.
How have Petmed Express IncPETS's recent earnings per share performed?
The market expectation was USD -0.31, while Petmed Express IncPETS's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD -0.11.
What is the analyst rating for Petmed Express Inc?
Based on the ratings of Petmed Express Inc's stock from 1 analysts, most analysts support a Sell trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Sell. Please note that this is not trading advice. You still need to conduct your own analysis.